HHS. Trends in prescription drug spending 2016–2021. https://aspe.hhs.gov/sites/default/files/documents/88c547c976e915fc31fe2c6903ac0bc9/sdp-trends-prescription-drug-spending.pdf Accessed July24, 2023.
2.
Kaiser Family Foundation. Number of retail prescription drugs filled at pharmacies by payer. https://www.kff.org/health-costs/state-indicator/total-retail-rx-drugs/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D Accessed July24, 2023.
3.
YoungEH, PanS, YapAG, RevelesKR, BhaktaK. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016. PLoS One, 2021; 16:1–10.
FDA. FDA table of pharmacogenomic biomarkers in drug labeling. 2022. https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling Accessed July31, 2023.
6.
BunkaM, WongG, KimD, et al.Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: a rapid review and meta-analysis. Psychiatry Res, 2023; 321:115102.
7.
DavidV, FylanB, BryantE, SmithH, SagooGS, RattrayM. An analysis of pharmacogenomic-guided pathways and their effect on medication changes and hospital admissions: a systematic review and meta-analysis. Front Genet, 2021; 12:698148.
8.
DowdD, WilliamsG, KrauseD, et al.Predicting potential drug-drug-gene interactions in a population of individuals utilizing a Community-Based Pharmacy. CNS Spectr, 2022; 27:236–237.
